Page last updated: 2024-11-03

pyrimethamine and Parkinsonian Disorders

pyrimethamine has been researched along with Parkinsonian Disorders in 1 studies

Maloprim: contains above 2 cpds

Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murakami, T1
Nakajima, M1
Nakamura, T1
Hara, A1
Uyama, E1
Mita, S1
Matsushita, S1
Uchino, M1

Reviews

1 review available for pyrimethamine and Parkinsonian Disorders

ArticleYear
Parkinsonian symptoms as an initial manifestation in a Japanese patient with acquired immunodeficiency syndrome and Toxoplasma infection.
    Internal medicine (Tokyo, Japan), 2000, Volume: 39, Issue:12

    Topics: AIDS-Related Opportunistic Infections; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active;

2000